{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:50:28Z","timestamp":1791359428316,"version":"4.3.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To analyze the patient characteristics, initial outcomes, and complications associated with iStent implantation in Indian eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective case series comprised subjects who underwent iStent, iStent inject, or iStent inject W implantation as a standalone procedure or combined with phacoemulsification with at least 12 months follow-up. The main outcome measures were change in intraocular pressure (IOP) and number of anti-glaucoma medication (AGM), post op complications, and resurgery rates at the final follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 56 eyes of 46 patients were included. Twenty-six eyes received iStent, and 30 eyes received either iStent inject or iStent inject W. Mean IOP reduced by 25.5%, and the mean number of AGM decreased by 75.8% at final follow-up (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.005). The overall success rate was achieved in 51 eyes (85%). When compared to standalone iStent, combined phacoemulsification with iStent delivered greater reduction in AGM (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004). Compared to iStent, eyes with iStent inject and inject W had better IOP reduction (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03), lesser AGM (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.005), and a lesser number of surgical failures (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.045). Three months after iStent inject implantation, trabeculectomy was performed in one eye with secondary glaucoma. Postoperative IOP rise due to steroid response was observed in 20 eyes (35.7%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>iStent implantation in Indian eyes demonstrated promising outcomes in reducing both intraocular pressure and anti-glaucoma medication burden. While combined procedures exhibited superior efficacy in reducing IOP and AGM, postoperative complications such as steroid-induced IOP rise were observed, emphasizing the importance of careful monitoring and management in optimizing surgical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_981_25","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:04:13Z","timestamp":1790690653000},"page":"1473-1477","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective analysis of indications and outcomes of trabecular micro-bypass stent implantation in Indian eyes"],"prefix":"10.4103","volume":"74","author":[{"given":"Amit","family":"Pandey","sequence":"first","affiliation":[{"name":"Medical City for Military and Security Services, AlKhoudh, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Centre for Sight Eye Hospital, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kathuria","sequence":"additional","affiliation":[{"name":"Centre for Sight Eye Hospital, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagarika","family":"Patyal","sequence":"additional","affiliation":[{"name":"Centre for Sight Eye Hospital, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Singh","sequence":"additional","affiliation":[{"name":"Centre for Sight Eye Hospital, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavini","family":"Pandey","sequence":"additional","affiliation":[{"name":"Medical City for Military and Security Services, AlKhoudh, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"R1-20261007","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R2-20261007","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.4103\/ijo.IJO_2008_20","article-title":"An exploratory study of compliance to anti-glaucoma medications among literate primary glaucoma patients at an urban tertiary eye care center in South India","volume":"69","author":"Ramesh","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R3-20261007","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","article-title":"The most common barriers to glaucoma medication adherence: A cross sectional survey","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"R4-20261007","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ophtha.2022.07.004","article-title":"Postoperative Complications in the primary tube versus trabeculectomy study during 5 years of follow-up","volume":"129","author":"Gedde","year":"2022","journal-title":"Ophthalmology"},{"issue":"3","key":"R5-20261007","first-page":"CD012743","article-title":"Ab interno trabecular bypass surgery with iStent for open-angle glaucoma","volume":"28","author":"Le","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20261007","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.4103\/ijo.IJO_308_21","article-title":"iStent versus iStent inject implantation combined with phacoemulsification in open angle glaucoma","volume":"69","author":"Shalaby","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R7-20261007","first-page":"8754730","article-title":"Use of iStent as a standalone operation in patients with open-angle glaucoma","volume":"2020","author":"Chen","year":"2020","journal-title":"J Ophthalmol"},{"key":"R8-20261007","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/ceo.13526","article-title":"Minimally invasive glaucoma surgery: Comparison of iStent with iStent inject in primary open angle glaucoma","volume":"47","author":"Hooshmand","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"R9-20261007","doi-asserted-by":"crossref","first-page":"19117","DOI":"10.1016\/j.jcrs.2012.07.017","article-title":"Using multiple trabecular micro bypass stents in cataract patients to treat open angle glaucoma","volume":"38","author":"Belovay","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"R10-20261007","first-page":"4425","article-title":"Evaluating the trabecular microbypass stent combined with phacoemulsification compared to phacoemulsification alone","volume":"232","author":"El Wardani","year":"2015","journal-title":"Klin Monbl Augenheilkd"},{"key":"R11-20261007","first-page":"231320","article-title":"Prospective, randomized study of one, two, or three trabecular bypass stents in openangle glaucoma subjects on topical hypotensive medication","volume":"9","author":"Katz","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"R12-20261007","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s12325-024-02788-y","article-title":"7-year efficacy and safety of iStent inject trabecular micro-bypass in combined and standalone usage","volume":"41","author":"Hengerer","year":"2024","journal-title":"Adv Ther"},{"key":"R13-20261007","first-page":"875","article-title":"Prospective unmasked randomized evaluation of the iStent inject versus two ocular hypotensive agents in patients with primary open angle glaucoma","volume":"8","author":"Fea","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"R14-20261007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12325-014-0095-y","article-title":"Prospective, unmasked evaluation of the iStent inject system for open-angle glaucoma: Synergy trial","volume":"31","author":"Voskanyan","year":"2014","journal-title":"Adv Ther"},{"key":"R15-20261007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2023.02.014","article-title":"Long-term endothelial safety profile with iStent inject in patients with open-angle glaucoma","volume":"252","author":"Ahmed","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"R16-20261007","first-page":"105","article-title":"Efficacy and safety of istent inject implantation in manual and femtosecond laser-assisted cataract surgery before lens extraction","volume":"6","author":"Manning","year":"2022","journal-title":"J Curr Glaucoma Pract"},{"key":"R17-20261007","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","article-title":"Prospective, randomized, controlled pivotal trial of an Ab interno implanted trabecular microbypass in primary open angle glaucoma and cataract: Two-year results","volume":"126","author":"Samuelson","year":"2019","journal-title":"Ophthalmology"},{"key":"R18-20261007","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s12325-019-00984-9","article-title":"Second generation trabecular microbypass stents as standalone treatment for glaucoma: A 36-month prospective study","volume":"36","author":"Hengerer","year":"2019","journal-title":"Adv Ther"},{"key":"R19-20261007","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40123-019-00214-z","article-title":"One-year outcomes of second generation trabecular microbypass stents (iStent Inject) implantation with cataract surgery in different glaucoma subtypes and severities","volume":"8","author":"Salimi","year":"2019","journal-title":"Ophthalmol Ther"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_981_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:00:51Z","timestamp":1791356451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_981_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_981_25","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"2025-04-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}